Is it possible to work with autistic people in a regular workplace? - Project ‘Opportunity’ has proven that a controlled and thoughtful approach to integration can provide a company with valuable staff and autistic people with a job, purpose and satisfaction.
It may be hard to believe but a pharmacy talk can actually be entertaining. Prof Derek Stewart made sure of that whilst conveying some important key insights of his group’s research.
Daclizumab, marketed as Zinbryta, was approved for the treatment of relapsing-remitting multiple sclerosis (MS) in the USA and Europe in summer 2016. Daclizumab has shown superior efficacy when compared to placebo and a standard treatment (AVONEX®, interferon beta-1a) and is believed to be on a par with other novel treatments. It is a once-monthly subcutaneous injection which the patient can administer themselves. This is quite convenient to be honest and if you aren’t into injecting yourself, you can go to your doctor as far as I have heard.
After I tweeted about my recent post Immunicum - Scalable Personalised Cancer Immunotherapy, another Twitter user made me aware of iCancer. Why? – Because the clinical trial financed through the iCancer fundraising campaign used the Ad5PTDf35-adenovirus vector which Immunicum includes as one of their treatment platforms under development.